돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 654728생성일: 2026년 10월 24일

Dichloromethane → Tobramycin

https://huagongshe.com/ko/reaction/654728

반응식

참여 물질

역할이름HCID투입량
반응물DichloromethaneHCID 6344—
반응물Tobramycin Sulphate SaltHCID 62005—
용매WaterHCID 962—
생성물TobramycinHCID 36294—

반응 단계

To a solution of 50 ml of dichloromethane was added 10 grams of soy lecithin and 200 mg of tobramycin sulfate in 5 ml of water. Fifty ml of additional dichloromethane was added and the solution was mixed by shaking. Eight ml of solution (4 ml per side) was added to a 1"×1" foam wound bandage material which was then allowed to air dry. The materials were analyzed for residual dichloromethane by high pressure liquid chromatography and found to contain no detectable residual dichloromethane. The 1"×1" foam wound materials were packaged individually in heat sealed bags and stored at room temperature for two months. At the end of two months the packages were opened and a representative first sample of SDMC-forming foam wound bandages were removed, placed onto grid supports, and wetted with 5 ml of water. Two ml of eluent containing SDMC-entrapped tobramycin were collected from the first sample. A second representative sample of SDMC-forming foam wound bandages were stressed by heating to +70° C. for three days. A third representative sample of SDMC-forming foam wound bandages were stressed by freezing at -70° C. for three days, then allowed to equilibrate to room temperature. These stressed foam wound dressings were then placed onto grid supports, wetted with 5 ml of water, and 2 ml of eluent containing SDMC-entrapped tobramycin was collected. All samples were subjected to analysis for tobramycin entrapped as explained in Example 3. The results are shown in Table VII.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US05133965
출처 데이터셋uspto-grants-1992_07
ORD IDord-569d720804c447c2bd1725e9b07ea2ed
출처 메모uspto-grants-1992_07